Skip to main content
Wiley Open Access Collection logoLink to Wiley Open Access Collection
. 2026 Aug 14;27(15):e70501. doi: 10.1002/cbic.70501

Metabolic Labeling of Phosphatidylethanolamine Lipids in Cells Using Clickable Ethanolamine Analogs

Robert J Maraski 1, Jinchao Lou 1, Todd B Reynolds 2, Michael D Best 1,✉
PMCID: PMC13475593  PMID: 42599685

Abstract

Phosphatidylethanolamine (PE) is the second most abundant phospholipid in mammalian cells. The cone‐shaped structure of PE positions this lipid to act as a cornerstone of signaling events, such as those involving protein–protein and lipid–protein interactions, as it has been shown to promote conformational changes in both protein and lipid‐based membrane structures. Despite this importance, chemical tools to interrogate the biological activity and trafficking of PE lipids are limited. Herein, we report the development of ethanolamine probes functionalized with clickable tags that are capable of infiltrating native cellular pathways and subsequently producing labeled PE lipids. Derivatization of click‐tagged PE products enabled fluorescence microscopy imaging of these lipids in cells. Interrogation of the efficacy of these probes for biological incorporation was conducted using mass spectrometry and thin‐layer chromatography analysis to identify various species of tagged PE molecules. This approach provides an invaluable step toward metabolic labeling strategies that will aid in the tracking of PE biosynthesis and trafficking pathways in cells.

Keywords: click chemistry, lipids, metabolic labeling, phosphatidylethanolamine


This work describes the metabolic labeling of phosphatidylethanolamine (PE) lipids using clickable ethanolamine substrate analogs. Post‐derivatization of tagged PE in cells via click chemistry enabled detection using fluorescence microscopy, mass spectrometry, and TLC imaging.

graphic file with name CBIC-27-e70501-g001.jpg

1. Introduction

Phosphatidylethanolamine (PE) is a zwitterionic phospholipid that comprises between 15% and 20% of total lipid composition in mammalian cells [1]. This lipid plays crucial roles in biological processes, such as the regulation of autophagy and the formation of nonbilayer lipid structures within both yeast and mammalian cells [2]. Dysregulation of PE has been associated with insulin resistance and skeletal muscle dysfunction, as well as diseases such as cancer and diabetes [3, 4]. Given its essential roles, the ability to effectively label and track PE is crucial in gaining further understanding of the metabolism, trafficking, and biological activities of this lipid.

PE is a downstream product of three pathways in yeast cells. First, it can be produced in the endoplasmic reticulum (ER) via the Kennedy pathway from the precursors of imported ethanolamine (ETA) or ETA‐phosphate derived from phosphorylated sphingoid bases. The other two pathways form PE in the mitochondrion and endosomal membranes from PS through decarboxylation of phosphatidylserine (PS) to PE by PS decarboxylase I and II, respectively [5, 6]. In all three pathways, PE can be subsequently converted to phosphatidylcholine (PC) through PE N‐methyltransferase (PEMT) activities of two related enzymes [7]. PC composes up to 50% of total phospholipids in mammalian cells and is crucial in maintaining membrane lipid homeostasis and the production of lipid signaling molecules [8, 9]. PC can be generated from choline and diacylglycerol (DAG) via the Kennedy pathway, but between 10% and 40% of all PC in mammalian cells is generated from PE via PEMT [10]. The multitude of crucial functions coupled with the dysregulation of PC being linked to disease progression indicates that the ability to track PE could also lead to downstream developments elucidating PC metabolism [11].

An increased recognition of the importance of lipids as biological mediators and signaling molecules has given rise to lipid metabolic labeling studies, which involve the introduction of minimally modified substrate‐adjacent biomolecules into cells [12]. Phospholipids provide particularly enticing targets for labeling studies, as they undergo complex interconversions between many different lipid species, are found throughout all parts of the cell, but with individual lipids exhibiting specific subcellular localization, and their dysregulation is linked to various diseases [1]. Strategies such as isotopic labeling were originally employed to elucidate lipid pathways and have been vital for advancing the understanding of lipid activity and metabolism through the subtle introduction of heavy atoms [13]. This enables detection based on mass, while recent developments have provided tools capable of organelle‐specific imaging [14, 16].

An effective alternative approach has involved the installation of bioorthogonal/clickable functional groups onto biologically active substrates, a strategy that has demonstrated the ability to precisely track lipids, nucleotides, and other important biomolecules [17, 18]. In addition to elucidating the localization of these biomolecules, a clickable handle enables the ability to introduce diverse functionality, which has been applied to identify novel proteins based on their activity and provide insight into the metabolic activity of enzymes [19, 20]. In the medical realm, click chemistry has been used to develop new therapeutic scaffolds to enhance drug efficacy [21]. Bioorthogonal handles have been tuned to be unreactive within the confines of native biological systems yet undergo rapid and observable modifications in the presence of their specific click tag partners [22]. Perhaps the most prominent of these click partners are the azide and alkyne, which have been demonstrated to undergo both copper‐catalyzed azide‐alkyne cycloaddition (CuAAC) and strain‐promoted azide‐alkyne cycloaddition (SPAAC) reactions at high rates and yields within complex biological systems [23]. Due to their diminutive size, both the azide and alkyne have been shown to minimally affect metabolic modification of biomolecules into which they have been appended, enabling their utility for furthering our knowledge of glycerophospholipids (GPLs) and other biologically pertinent compounds [24].

Prior work in the field has demonstrated the infiltration of multiple lipid pathways through the introduction of clickable lipid precursors [25, 26]. Salic and coworkers initially showcased this approach by developing clickable choline analogs to produce labeled PC [27, 28]. Inositol‐containing lipids have also been successfully labeled using clickable inositol probes targeting both glycophosphatidylinositol (GPI) anchors [29] and phosphatidylinositol (PI) lipids [30]. Baskin and coworkers have hijacked phospholipase D (PLD) enzymes to incorporate clickable tags into phosphatidic acid (PA) lipids to investigate both PLD and PA dynamics [31]. Our group has also shown the labeling of PS products in cells using clickable serine analogs as substrates [32]. Furthermore, we have also worked to more globally label GPLs using tagged glycerol [33] and caged glycerol‐3‐phosphate [34] probes that can be incorporated into the core scaffold of a variety of GPLs. The current work expands this toolbox to now enable the labeling of important PE lipids using clickable ETA substrate precursors, which is expected to enhance the ability to track the biosynthesis and trafficking of PE in cells.

2. Results and Discussion

The desired function for a synthetic probe employed for metabolic labeling is to maximize target product labeling by minimally disturbing metabolic pathways, which can be done by utilizing innate cellular pathways for processes such as cell entry and incorporation. As previously mentioned, despite multiple biosynthetic pathways for producing PE, ETA is the common precursor that enters the Kennedy pathway to produce PE lipids, and therefore this is the substrate on which we based our probes. Despite the innate positive charge of ETA at physiological pH, which could pose problems for crossing the plasma membrane, mammalian cells alleviate this issue by utilizing energy‐dependent transporters embedded in the cell membrane [35]. Therefore, it is important to minimize alterations to probe structures to avoid interference with cellular uptake. We elected to perform initial metabolic incorporation studies in the yeast S. cerevisiae, which shares similarities in genes, enzymes, and lipid metabolism pathways with mammalian cells [36]. Although studies of S. cerevisiae‐specific ETA transport mechanisms are limited, their cells also contain active transporter proteins, indicating that the shuttling process is likely conserved [5]. Our probe design leverages this proposed cellular uptake by closely mimicking the native structure of ETA. Following cell entry, we expected that our synthetic probes, ETA‐R‐N 3 and ETA‐S‐N 3 , would infiltrate lipid metabolism via the Kennedy pathway by first undergoing phosphorylation catalyzed by ETA kinase to produce a labeled version of ETA phosphate (PEtN), then coupling with cytidine triphosphate (CTP) to form CDP‐ETA, and finally being converted to labeled PE (Figure 1) [37, 38].

FIGURE 1.

FIGURE 1

Proposed process for PE labeling using probes ETA‐R‐N 3 and ETA‐S‐N 3 . Probes are expected to first be shuttled into the cytosol, where they will then enter the ER and undergo phosphorylation, forming a phosphoethanolamine analog. Subsequent coupling will yield labeled CDP‐ethanolamine, which will finally be converted to clickable PE‐R/S‐N3 for product labeling and tracking.

To enable post‐derivatization of PE products, probes ETA‐R‐N 3 and ETA‐S‐N 3 both contain an added azidomethylene group similar to previously successful modifications. Of the two potential carbons on ETA to install the azidomethylene, we speculated that maximizing distance from the primary alcohol could aid probe infiltration by reducing potential steric interactions, as the alcohol moiety undergoes phosphorylation during lipid formation. Furthermore, we recognized that the addition of the azide tag at this position introduces a new stereocenter in these probes. To address this potential issue, we devised a synthetic route to produce both stereoisomers independently and determine if the newly added stereocenter affects labeling within chiral enzyme environments.

The synthetic route to enantiomeric probes ETA‐R‐N 3 and ETA‐S‐N 3 is shown in Scheme 1. Both enantiomers of tert‐butyl (R/S)‐4‐(hydroxymethyl)‐2,2‐dimethyloxazolidine‐3‐carboxylate starting materials (1.1 and 2.1, respectively) were chosen because these enable selective modifications that can be followed by complete acidic deprotection after azide substitution. Both starting materials initially underwent tosylation of the primary alcohol to produce 1.2/2.2, followed by subsequent azide substitution resulting in 1.3/2.3. Acidic deprotection culminated in the formation of the desired probes ETA‐R‐N 3 and ETA‐S‐N 3 . We further utilized these final structures to synthesize negative control compounds, Me‐ETA‐R‐N 3 and Me‐ETA‐S‐N 3 , in which the hydroxyl group is methylated, blocking the phosphorylation site required to biosynthesize PE (SI pages S8–S10).

SCHEME 1.

SCHEME 1

Synthetic route to ETA‐R‐N 3 and ETA‐S‐N 3 probes. These compounds were obtained by tosylation of 1.1/2.1 to 1.2/2.2, azide substitution to 1.3/2.3, and acidic deprotection ETA‐R‐N 3 /ETA‐S‐N 3 . Compounds Me‐ETA‐R‐N 3 and Me‐ETA‐S‐N 3 were also synthesized as negative controls (SI pages S8–S10).

2.1. Probe Effects on Cell Growth

Following the synthesis of ETA‐R‐N 3 and ETA‐S‐N 3 , these probes were incubated with Saccharomyces cerevisiae yeast cells (TRY 181 (wild‐type, uraΔhisΔ)) to scrutinize their effects on cell proliferation and overall toxicity via monitoring their growth over an extended period. In this study, four groups of cells were interrogated over the span of 48 h using 2% galactose liquid media. Of the four groups, the first cells underwent no treatment (NT), the second was a no probe control (NPC), which was treated with water (the probe solvent), and the final two consisted of cells treated with probe ETA‐R‐N 3 or ETA‐S‐N 3 such that the final concentration of probe was 1 mM in media. At the beginning of the 48 h period, all groups shared the same OD600 (optical density at 600 nm) of 0.2. Following initial incubation, OD600 values were gathered at seven different times during the 48 h period and plotted as a function of time. As shown in Figure 2A, there was no significant shift in growth for any of the groups until the stationary phase; all samples grew in accordance with the NT group during the lag and log phases and exhibited minimal variation in doubling time, which was calculated from 0–18 h (Figure 2B). The negative controls Me‐ETA‐S‐N 3 and Me‐ETA‐R‐N 3 were also evaluated in a similar manner, where the only statistically significant difference in doubling time was between ETA‐R‐N 3 and Me‐ETA‐S‐N 3 (Figure S7). These results provided evidence that the addition of probes ETA‐R‐N 3 and ETA‐S‐N 3 at the given concentration did not result in metabolic changes that resulted in toxicity.

FIGURE 2.

FIGURE 2

Cell growth results with and without probe treatment. (A) No treatment (NT), no probe control (NPC), ETA‐S‐N3 , and ETA‐R‐N3 groups were incubated with cells beginning at an OD600 of 0.2 and growth was measured over a period of 48 h. Probes were incubated so the final concentration was 1 mM. The results showed minimal variation in cell growth upon probe treatment. Holm‐corrected Welch ANOVA values identified significant group differences at 36 h (p=3.09×10−5) and 48 h (p=0.0380). Games–Howell post hoc testing showed that ETA‐S‐N 3 and ETA‐R‐N 3 were higher than NT at 36 h (p=7.20×10−6 and p=9.33×10−6, respectively). At 48 h, ETA‐S‐N 3 and ETA‐R‐N 3 were higher than NT (p=0.0304 and p=0.0385) and NPC (p=0.0194 and p=0.0283), respectively. (B) Doubling times (0–18 h) calculated for the same four groups. Error bars represent mean ± standard deviation, with individual triplicate values each shown with an x. Statistical analysis was performed using Welch ANOVA with Games–Howell post‐hoc test. All pairwise comparisons were not significant (ns).

2.2. Microscopy Imaging Experiments

Next, our azido‐ETA probes were incubated with S. cerevisiae yeast cells to evaluate their efficacy for labeling cellular membranes and enabling detection using fluorescence microscopy. In addition to providing insight into localization and labeling efficacy, microscopy is also an essential tool for identifying the ideal conditions for cellular incubation of probes for future studies. During experiments in which we varied the duration and concentration of probe treatment, we found that incubation with 1 mM probe over a 2 h period yielded effective labeling (Figures 3 and S1). Longer times including 8 and 12 h incubations were also tested, but yielded minimal fluorescence over NPC samples, suggesting that rapid turnover of phospholipids could lead to cleavage of the clickable headgroup (data not shown). In each case, following probe incubation, cells were washed, fixed with paraformaldehyde, and then treated with dibenzocyclooctyne‐cyanine 3 (DBCO‐Cy3), a water‐soluble, orange‐emitting fluorophore containing a strained alkyne for SPAAC labeling of azide‐tagged products. Unreacted dye was then removed using washing steps and cell samples were visualized using a confocal fluorescence microscope. For consistency of metabolic incorporation that could vary depending on the cell culture growth phase, probes ETA‐S‐N 3 and ETA‐R‐N 3 , as well as negative controls Me‐ETA‐S‐N 3 and Me‐ETA‐R‐N 3 were incubated for 2 h for all subsequent microscopy, MS, and TLC studies.

FIGURE 3.

FIGURE 3

Fluorescence and bright field microscopy images of S. cerevisiae cells incubated with NPC (A), ETA‐S‐N 3 (B), or ETA‐R‐N 3 (C). Cells were fixed, treated with 1 µM Cy3‐DBCO for SPAAC coupling, and washed to remove unreacted dye. Images show significant labeling only when probes were added. Images are Z‐stacks containing 12 layered images with fluorescence maximized. MFI values were calculated using at least 8 images with a total of at least 55 cells. Scale bars depict 20 μm (D). Error bars represent mean ± standard deviation, with individual values shown as dots. Post‐hoc Welch's t‐tests with Bonferroni correction showed that both ETA‐S‐N3 and ETA‐R‐N3 groups had significantly higher fluorescence than NPC (****p < 0.0001 for each). Additionally, the difference in fluorescence between ETA‐S‐N3 and ETA‐R‐N3 was statistically significant (**p < 0.01;  ****p < 0.0001).

In addition to the clear difference in fluorescence resulting from probe treatment (Figure 3B,C compared to Figure 3A), labeling was also quantified by contrasting the mean fluorescence intensity (MFI) values between NPC studies and the two probes. The NPC cells were shown to exhibit an MFI of 17.7 ± 6.1, comprised mostly of background signal, whereas ETA‐S‐N 3 and ETA‐R‐N 3 MFIs were 62.9 ± 16.6 and 49.5 ± 17.3, respectively (Figure 3D). These differences in values compared to untreated controls provide evidence that these synthetic probes are effective at entering biological pathways as predicted. Additionally, cells treated with methylated compounds Me‐ETA‐R‐N 3 and Me‐ETA‐S‐N 3 were also imaged along with quantitation of fluorescence labeling. These compounds act as negative controls due to the blocking of the hydroxyl group required for connection to PE. Therefore, they can additionally inform about the extent to which residual probe is retained within cells, providing information about non‐specific fluorescence. The MFI values for these compounds were 25.57 ± 4.63 and 26.17 ± 4.50, respectively. This modest increase in MFI of the methylated compounds compared to the NPC indicates that a marginal amount of clickable probe is persisting following washing steps. More importantly, the MFI values for these compounds are significantly lower than those resulting from probes ETA‐S‐N 3 and ETA‐R‐N 3 , as expected, which provides further validation that those probes are effective at labeling PE lipids. It should also be noted that the majority of fluorescence is located at the plasma membranes of cells. While this supports lipid labeling, it is possible that challenges associated with dye permeability may be obstructing the labeling of PE lipids inside organelles.

2.3. Validation of PE Lipid Labeling

While microscopy provides crucial insight that probe infiltration has occurred, further experiments are necessary to characterize the identities of labeled products. This can be achieved through thin‐layer chromatography (TLC) and liquid chromatography/mass spectrometry (LCMS) analysis of lipid extracts, which have been shown to effectively identify phospholipids through differences in polarity and mass, respectively. For TLC studies, following the 2 h incubation time that was determined during microscopy studies, cellular lipids were extracted and subjected to CuAAC with ethynylnaphthalimide (Naphth). Naphth is a nonpolar fluorescent dye that was chosen for visualization of labeled lipid bands under UV while minimally affecting R f values. We used CuAAC in this case because TLC studies are performed using lipid extracts, rather than intact cells, and therefore copper delivery/toxicity is not an issue. The amount of time allowed for the click reaction and the identity of the TLC mobile phase were both analyzed during experiments. We determined a 3 h CuAAC time to be ideal and that two separate solvent mixtures in tandem could be used for the development of the plate. Plates were first developed with a polar eluant (chloroform/methanol/water/acetic acid = 65:25:4:1, v/v/v/v), which was subsequently switched to a nonpolar eluant mixture (cyclohexane/ethyl acetate = 1:1). The resulting plate was visualized under a UV lamp (Figure 4). The appearance of a new band with an R f value (0.35) that closely matched the commercial PE standard was observed from the lipid extracts of both enantiomeric probe‐containing lanes (Figure 4, lanes 4 and 5). While this band appeared at slightly higher R f than the PE standard (R f = 0.31), this can be explained by the clicked lipid products containing the hydrophobic dye Naphth appended to the structure for visualization purposes. This band is notably absent from the NPC lane (Figure 4, lane 3), as well as the lanes correlating to the methylated negative control compounds Me‐ETA‐S‐N 3 and Me‐ETA‐R‐N 3 (Figure S5). Figure 4 also shows the R f values of various commercial lipid standards, including natural PE (indicated by arrows to the left of the plate), for comparison. An additional band is present in lanes (1–2, 4–5) at R f = 0.23, but this correlates with the clicked ETA‐R/S‐N 3 stock solution, suggesting some residual probe is present. Nevertheless, the formation of a new band with similarities in R f values to PE provided initial evidence that probes ETA‐S‐N 3 and ETA‐R‐N 3 are capable of infiltrating lipid metabolic pathways of S. cerevisiae to produce functionalized PE derivatives.

FIGURE 4.

FIGURE 4

TLC image providing evidence that probes ETA‐S‐N 3 and ETA‐R‐N 3 label PE in cells. After cellular labeling, lipids were extracted, reacted through CuAAC with Naphth, and developed by TLC. Lanes 1 and 2 contain 0.5 mM probe only stock solutions that were clicked with Naphth. Lane 3 shows NPC lipid extracts treated with Naphth, while lanes 4 and 5 are extracts from cells treated with ETA‐R‐N 3 and ETA‐S‐N 3 and clicked with Naphth, respectively. Lane 6 contained only CuAAC. A new fluorescent band appeared in the ETA‐R‐N 3 and ETA‐S‐N 3 lanes coinciding with the commercially available lipid standard for PE, which is marked along other commercially available lipids that were spotted on the plate (Figure S4), indicating the formation of a new clicked PE species.

While TLC provides initial insight into the species of phospholipids present, in this case PE, LCMS is invaluable for further confirmation and to identify specific structural details of labeled lipids, such as the lipid tail length or unsaturation. For these experiments, following the 2 h incubation period, lipids were extracted from cells, but in this case were subjected to LCMS analysis. Due to the zwitterionic nature of PE, we scanned for and detected PE species in both positive and negative mode as both the [M − H]− or [M + H]+ ions. In addition to mass, a similar retention time for the natural and tagged lipids was observed, indicating comparable polarity between the labeled and unlabeled species, which is expected due to their related structures. Through these experiments we detected mass peaks correlating with various labeled PE lipid species (Table S1; representative spectra in Figure S6), indicating that ETA‐S‐N 3 and ETA‐R‐N 3 are effective at infiltrating cellular biochemical pathways, specifically the Kennedy pathway. In addition, we noticed a complete overlap between labeled phospholipids from each probe, demonstrating that the stereochemical configuration of the stereocenter does not impact lipid labeling properties. Interestingly, we did not observe any labeled PC lipid species either in positive or negative mode during LCMS studies. This was notable because labeled PE molecules could potentially undergo methylation into corresponding PC structures, particularly due to the abundant nature of the latter lipid. On the other hand, we did observe mass peaks correlating with phosphatidyl‐N,N‐dimethylethanolamine (PDME) species. Therefore, we hypothesize that the addition of an azidomethylene group could sterically hinder complete methylation to generate PC products.

3. Conclusions

The culmination of these studies indicates that our synthetic azide‐tagged ETA probes ETA‐S‐N 3 and ETA‐R‐N 3 are capable of infiltrating cellular pathways and acting as substrate mimetics to produce functionalized labeled PE species. Cellular growth studies indicated biocompatibility and minimal variability in cell proliferation of these probes in yeast cells. Fluorescence microscopy experiments showed that these probes were effective for the labeling of yeast cellular membranes. Furthermore, the ability of these probes to successfully undergo structural modifications to produce labeled PE molecules was supported by both TLC and MS experiments, which provided insight into the various PE species that were labeled. While quantitation of lipid labeling was considered, such experiments are complicated since they often require synthetic versions of each tagged lipid as internal standards, particularly since chromatographic retention times are similar for labeled and natural lipids. While this is a limitation of the current study, the primary focus of this work entailed qualitative validation of lipid labeling. Finally, our study of both stereoisomers of the newly found probes indicates that the stereochemistry at the position bearing the new azidomethylene group does not affect labeling activity. Therefore, it may be suitable and more convenient to employ these probes as a racemic mixture in future studies. These results demonstrate the effectiveness of ETA‐S‐N 3 and ETA‐R‐N 3 for infiltrating PE lipid metabolism, marking them as promising candidates for further investigations into lipid pathways and other lipid‐related cellular processes.

Funding

This work was supported by the National Science Foundation (Grant NSF‐CHE‐2310263).

Conflicts of Interest

The authors declare no conflicts of interest.

Supporting information

Additional synthetic information such as procedures and characterization data for compounds are described in the Supporting Information.

Acknowledgments

Research reported in this publication was supported by the National Science Foundation under award number NSF‐CHE‐2310263. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Science Foundation. The authors would like to acknowledge the University of Tennessee Advanced Microscopy and Imaging Center and Jaydeep Kolape, for instrument use, scientific and technical assistance. We also acknowledge Dr. Shawn R. Campagna and Dr. Katarina Jones at the UTK Biological and Small Molecule Mass Spectrometry Core for assistance with MS studies.

Data Availability Statement

The data that support the findings of this study are available from the corresponding author upon reasonable request.

References

  • 1. Dennis E. A. and Kennedy E. P., “Intracellular Sites of Lipid Synthesis and the Biogenesis of Mitochondria,” Journal of Lipid Research 13, no. 2 (1972): 263–267, 10.1016/S0022-2275(20)39421-9. [DOI] [PubMed] [Google Scholar]
  • 2. van Meer G., Voelker D. R., and Feigenson G. W., “Membrane Lipids: Where They Are and How They Behave,” Nature Reviews Molecular Cell Biology 9, no. 2 (2008): 112, 10.1038/nrm2330. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Grapentine S., Singh R. K., and Bakovic M., “Skeletal Muscle Consequences of Phosphatidylethanolamine Synthesis Deficiency,” Function 4, no. 4 (2023): zqad020, 10.1093/function/zqad020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Grapentine S. and Bakovic M., “Significance of Bilayer‐Forming Phospholipids for Skeletal Muscle Insulin Sensitivity and Mitochondrial Function,” The Journal of Biomedical Research 34, no. 1 (2020): 1–13, 10.7555/JBR.33.20180104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Birner R., Bürgermeister M., Schneiter R., Daum G. C., and Pringle J., “Roles of Phosphatidylethanolamine and of Its Several Biosynthetic Pathways in Saccharomyces Cerevisiae,” Molecular Biology of the Cell 12, no. 4 (2001): 997–1007, 10.1091/mbc.12.4.997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Trotter P. J. and Voelker D. R., “Identification of a Non‐Mitochondrial Phosphatidylserine Decarboxylase Activity (PSD2) in the Yeast Saccharomyces Cerevisiae,” Journal of Biological Chemistry 270, no. 11 (1995): 6062–6070, 10.1074/jbc.270.11.6062. [DOI] [PubMed] [Google Scholar]
  • 7. Preitschopf W., Lückl H., Summers E., Henry S. A., Paltauf F., and Kohlwein S. D., “Molecular Cloning of the Yeast OPI3 Gene as a High Copy Number Suppressor of the cho2 Mutation,” Current Genetics 23, no. 2 (1993): 95–101, 10.1007/BF00352006. [DOI] [PubMed] [Google Scholar]
  • 8. de Kroon A. I. P. M., “Metabolism of Phosphatidylcholine and Its Implications for Lipid Acyl Chain Composition in Saccharomyces Cerevisiae ,” Biochimica et Biophysica Acta (BBA) ‐ Molecular and Cell Biology of Lipids 1771, no. 3 (2007): 343–352, 10.1016/j.bbalip.2006.07.010. [DOI] [PubMed] [Google Scholar]
  • 9. Exton J. H., “Phosphatidylcholine Breakdown and Signal Transduction,” Biochimica et Biophysica Acta (BBA) ‐ Lipids and Lipid Metabolism 1212, no. 1 (1994): 26–42, 10.1016/0005-2760(94)90186-4. [DOI] [PubMed] [Google Scholar]
  • 10. Vance D. E., “Phospholipid Methylation in Mammals: From Biochemistry to Physiological Function,” Biochimica et Biophysica Acta (BBA) ‐ Biomembranes 1838, no. 6 (2014): 1477–1487, 10.1016/j.bbamem.2013.10.018. [DOI] [PubMed] [Google Scholar]
  • 11. van der Veen J. N., Kennelly J. P., Wan S., Vance J. E., Vance D. E., and Jacobs R. L., “The Critical Role of Phosphatidylcholine and Phosphatidylethanolamine Metabolism in Health and Disease,” Biochimica et Biophysica Acta (BBA) ‐ Biomembranes 1859, no. 9 (2017): 1558–1572, 10.1016/j.bbamem.2017.04.006. [DOI] [PubMed] [Google Scholar]
  • 12. Ancajas C. F., Ricks T. J., and Best M. D., “Metabolic Labeling of Glycerophospholipids via Clickable Analogs Derivatized at the Lipid Headgroup,” Chemistry and Physics of Lipids 232 (2020): 104971, 10.1016/j.chemphyslip.2020.104971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Wegener G., Kellermann M. Y., and Elvert M., “Tracking Activity and Function of Microorganisms by Stable Isotope Probing of Membrane Lipids,” Current Opinion in Biotechnology 41 (2016): 43–52, 10.1016/j.copbio.2016.04.022. [DOI] [PubMed] [Google Scholar]
  • 14. Ecker J. and Liebisch G., “Application of Stable Isotopes to Investigate the Metabolism of Fatty Acids, Glycerophospholipid and Sphingolipid Species,” Progress in Lipid Research 54 (2014): 14–31, 10.1016/j.plipres.2014.01.002. [DOI] [PubMed] [Google Scholar]
  • 15. Qin S., Zhang Y., Tian Y., Xu F., and Zhang P., “Metabolomics: Isolation, Measurement, and Applications,” Journal of Pharmaceutical and Biomedical Analysis 210 (2022): 114557, 10.1016/j.jpba.2021.114557. [DOI] [PubMed] [Google Scholar]
  • 16. Šlachtová V., Chovanec M., Rahm M., and Vrabel M., “Bioorthogonal Chemistry in Cellular Organelles,” Topics in Current Chemistry 382, no. 1 (2023): 2, 10.1007/s41061-023-00446-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Sletten E M. and Bertozzi C R., “Bioorthogonal Chemistry: Fishing for Selectivity in a Sea of Functionality,” Angewandte Chemie International Edition 48, no. 38 (2009): 6974–6998, 10.1002/anie.200900942. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. Fantoni Nò Z., El‐Sagheer A. H., and Brown T., “A Hitchhiker's Guide to Click‐Chemistry With Nucleic Acids,” Chemical Reviews 121, no. 12 (2021): 7122–7154, 10.1021/acs.chemrev.0c00928. [DOI] [PubMed] [Google Scholar]
  • 19. Li Y., Tian C., Liu K., Zhou Y., Yang J., and Zou P., “A Clickable APEX Probe for Proximity‐Dependent Proteomic Profiling in Yeast,” Cell Chemical Biology 27, no. 7 (2020): 858–865.e8, 10.1016/j.chembiol.2020.05.006. [DOI] [PubMed] [Google Scholar]
  • 20. Parker C. G., and Pratt M. R., “Chemistry in Proteomic Investigations,” Cell 180, no. 4 (2020): 605–632, 10.1016/j.cell.2020.01.025. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. Bhatia S., Biharee A., Mondal S., Kulkarni S., Kumar R., and Thareja S., “Mechanistic Analysis of Diverse Click Reactions Along With Their Applications,” European Journal of Medicinal Chemistry 296 (2025): 117800, 10.1016/j.ejmech.2025.117800. [DOI] [PubMed] [Google Scholar]
  • 22. Devaraj N. K. and Finn M. G., “Introduction: Click Chemistry,” Chemical Reviews 121, no. 12 (2021): 6697–6698, 10.1021/acs.chemrev.1c00469. [DOI] [PubMed] [Google Scholar]
  • 23. Oprea I. and Smith T. K., “Click Chemistry Methodology: The Novel Paintbrush of Drug Design,” ACS Chemical Biology 20, no. 1 (2025): 19–32, 10.1021/acschembio.4c00608. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. Ragab S. S., “Signature of Click Chemistry in Advanced Techniques for Cancer Therapeutics,” RSC Advances 15, no. 14 (2025): 10583–10601, 10.1039/d5ra01196e. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. Chen P.‐H. B., Li X.‐L., and Baskin J. M., “Synthetic Lipid Biology,” Chemical Reviews 125, no. 4 (2025): 2502–2560, 10.1021/acs.chemrev.4c00761. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. Best M. D., “Click Chemistry and Bioorthogonal Reactions: Unprecedented Selectivity in the Labeling of Biological Molecules,” Biochemistry 48, no. 28 (2009): 6571–6584, 10.1021/bi9007726. [DOI] [PubMed] [Google Scholar]
  • 27. Jao C. Y., Roth M., Welti R., and Salic A., “Biosynthetic Labeling and Two‐Color Imaging of Phospholipids in Cells,” ChemBioChem 16, no. 3 (2015): 472–476, 10.1002/cbic.201402149 [DOI] [PubMed] [Google Scholar]
  • 28. Jao C. Y., Roth M., Welti R., and Salic A., “Metabolic Labeling and Direct Imaging of Choline Phospholipids In Vivo,” Proceedings of the National Academy of Sciences 106, no. 36 (2009): 15332–15337, 10.1073/pnas.0907864106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29. Guo Z., “Synthetic Studies of Glycosylphosphatidylinositol (GPI) Anchors and GPI‐Anchored Peptides, Glycopeptides, and Proteins,” Current Organic Synthesis 10, no. 3 (2013): 366–383, 10.2174/1570179411310030003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30. Ricks T. J., Cassilly C. D., Carr A. J., et al., “Labeling of Phosphatidylinositol Lipid Products in Cells via Metabolic Engineering Using a Clickable Myo‐Inositol Probe,” Chembiochem 20, no. 2 (2019): 172–180, 10.1002/cbic.201800248 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31. Bumpus T. W. and Baskin J. M., “Clickable Substrate Mimics Enable Imaging of Phospholipase D Activity,” ACS Central Science 3, no. 10 (2017): 1070–1077, 10.1021/acscentsci.7b00222. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32. Ancajas C. F., Alam S., Alves D. S., et al., “Cellular Labeling of Phosphatidylserine Using Clickable Serine Probes,” ACS Chemical Biology 18, no. 2 (2023): 377–384, 10.1021/acschembio.2c00813. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33. Ancajas C. F., Carr A. J., Lou J., et al., “Harnessing Clickable Acylated Glycerol Probes as Chemical Tools for Tracking Glycerolipid Metabolism,” Chemistry – A European Journal 29, no. 38 (2023): e202300417, 10.1002/chem.202300417. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34. Lou J., Ancajas C. F., Zhou Y., Lane N. S., Reynolds T. B., and Best M. D., “Probing Glycerolipid Metabolism Using a Caged Clickable Glycerol‐3‐Phosphate Probe,” ChemBioChem 25, no. 18 (2024): e202300853, 10.1002/cbic.202300853. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35. Rockenfeller P., Koska M., Pietrocola F., et al., “Phosphatidylethanolamine Positively Regulates Autophagy and Longevity,” Cell Death & Differentiation 22, no. 3 (2015): 499–508, 10.1038/cdd.2014.219. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36. Henry S. A., Kohlwein S. D., and Carman G. M., “Metabolism and Regulation of Glycerolipids in the Yeast Saccharomyces Cerevisiae,” Genetics 190, no. 2 (2012): 317–349, 10.1534/genetics.111.130286. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37. Kim K., Kim K.‐H., Storey M. K., Voelker D. R., and Carman G. M., “Isolation and Characterization of the Saccharomyces Cerevisiae EKI1 Gene Encoding Ethanolamine Kinase,” Journal of Biological Chemistry 274, no. 21 (1999): 14857–14866, 10.1074/jbc.274.21.14857. [DOI] [PubMed] [Google Scholar]
  • 38. Carman G. M. and Han G.‐S., “Regulation of Phospholipid Synthesis in the Yeast Saccharomyces Cerevisiae ,” Annual Review of Biochemistry 80 (2011): 859, 10.1146/annurev-biochem-060409-092229. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Additional synthetic information such as procedures and characterization data for compounds are described in the Supporting Information.

Data Availability Statement

The data that support the findings of this study are available from the corresponding author upon reasonable request.


Articles from Chembiochem are provided here courtesy of Wiley

RESOURCES